Atlas Trials

A Study to Investigate the Effects of ACT-541468 on Nighttime Respiratory Function in Patients With Mild to Moderate Obstructive Sleep Apnea

Clinical trial NCT03765294 · COMPLETED

Trial details

NCT number
NCT03765294
Sponsor
Idorsia Pharmaceuticals Ltd.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Obstructive Sleep Apnea
Start date
2019-03-14
Primary completion
2019-11-05
Enrollment
28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.